Keywords: gilead, starts, cidofovir, gel, trials, genital, herpes

Gilead Starts Cidofovir Gel Trials In Genital Herpes Patients

Article | 29 May 1995

Print This

Gilead Sciences has begun a Phase I/II study of cidofovir topical gel in immunocompetent patients with recurrent genital herpes ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in